Current management of muscle-invasive bladder cancer

• Autores: Gemma Sancho, Pablo Maroto Rey, Joan Palou Redorta
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 13, Nº. 12, 2011, págs. 855-861
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Management of muscle-invasive bladder cancer (MIBC) has changed little in the last twenty years. The gold standard treatment is still cystectomy, but it has a significant negative impact on quality of life. Bladder-preservation strategies can be used in some cases but patient selection for this approach remains unclear. New chemotherapy and biologic agents in combination with surgery or radiotherapy could improve results and these possibilities are currently under investigation.